Nobuhiko Seki
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Epidemiology top 10%
- Physiology top 10%
- Co-authors
- Tetsuo HimiKenji EguchiHideaki ShirasakiTakashi SetoKazutsugu UematsuMegumi KikuchiEtsukó KanaizumiTakeharu Yamanaka
- Topics
- Lung Cancer Treatments and Mutations (27 papers)Lung Cancer Research Studies (15 papers)Asthma and respiratory diseases (13 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology
- Partner nations
- JapanChinaUnited States
In The Last Decade
Nobuhiko Seki
103 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 104
- Oncology 812
- Pulmonary and Respiratory Medicine 525
- Molecular Biology 374
- Epidemiology 290
- Physiology 227
Countries citing papers authored by Nobuhiko Seki
This map shows the geographic impact of Nobuhiko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiko Seki more than expected).
Fields of papers citing papers by Nobuhiko Seki
This network shows the impact of papers produced by Nobuhiko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiko Seki. The network helps show where Nobuhiko Seki may publish in the future.
Co-authorship network of co-authors of Nobuhiko Seki
This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiko Seki. A scholar is included among the top collaborators of Nobuhiko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiko Seki. Nobuhiko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 17 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 0 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer]. | 1 |
| 14 | 11 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 0 |
About Nobuhiko Seki
Nobuhiko Seki is a scholar working on Oncology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (15 papers) and Asthma and respiratory diseases (13 papers). The work is most often cited by research in Oncology (812 citations), Immunology and Allergy (124 citations) and Pulmonary and Respiratory Medicine (525 citations). Nobuhiko Seki has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Tetsuo Himi, Kenji Eguchi, Hideaki Shirasaki, Takashi Seto, Kazutsugu Uematsu, Megumi Kikuchi, Etsukó Kanaizumi, Takeharu Yamanaka, Norihiro Suzuki and Yoshikazu Hasegawa. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.